Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reaso

Abivax shares rise on renewed takeover speculation tied to Eli Lilly following strong Phase 3 trial

INDIANAPOLIS , July 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the s

INDIANAPOLIS , July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Verve Therapeutic

Investing in biotechnology stocks is similar to the drug development process itself. That is, invest

Shares in Verve Therapeutics (VERV -0.54%) soared 80.5% this week on the news of an agreement for El

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a str

LLY's move to buy Verve ignites investor interest across gene-editing stocks like CRSP, NTLA and BEA

VERV jumps on Eli Lilly's buyout offer, adding next-gen gene-editing therapies to the pharma giant's

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Shares of Verve Therapeutics (VERV 76.24%) were skyrocketing 75.7% higher as of 10:50 a.m. ET on Tue

Biotech stock Verve Therapeutics Inc (NASDAQ:VERV) is up 75.3% to trade at $10.99 at last check amid

Verve Therapeutics stock nearly doubled Tuesday after Eli Lilly agreed to buy the gene-editing compa

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Verve (Nasdaq: VERV) for possible breach

Eli Lilly agreed to acquire Verve Therapeutics for approximately $1 billion up front, adding a poten

Eli Lilly will acquire Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday.

Verve's leading programs aim to deliver lifelong cardiovascular risk reduction with a single dose by

A report said the two pharmaceutical companies are in advance talks.

Eli Lilly and Co (NYSE:LLY) is in advanced discussions to acquire Verve Therapeutics in a deal worth

Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 bil

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showca

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on Tue

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourt

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on T

Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the

StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat res

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the compan

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big

  On Wednesday, 179 companies reached new 52-week lows.

  On Tuesday, 99 stocks hit new 52-week lows.

The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight

U.S. stocks traded higher, with the Dow Jones gaining around 180 points on Thursday. Here are some b

Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, la